TABLE OF CONTENTS
| | | | Volume 20, Issue 2 (June 2017) | | In this issue Reviews Original Articles Letters to the Editor Errata
Also new AOP
| | | | | Advertisement | | Celebrating 20 years of Prostate Cancer and Prostatic Diseases — 1997 to 2017
Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone.
Watch our anniversary video showing a brief impact overview >>> | | | | | Reviews | Top | | Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature reviewM I Gökce, D Sundi, E Schaeffer and C Pettaway Prostate Cancer Prostatic Dis 2017 20: 127-136; advance online publication, April 18, 2017; 10.1038/pcan.2016.56 Abstract | Full Text | | | | Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update OPENP J Owen, R M Daly, P M Livingston and S F Fraser Prostate Cancer Prostatic Dis 2017 20: 137-145; advance online publication, January 24, 2017; 10.1038/pcan.2016.69 Abstract | Full Text | | | | Meta-analysis of metabolic syndrome and prostate cancerM Gacci, G I Russo, C De Nunzio, A Sebastianelli, M Salvi, L Vignozzi, A Tubaro, G Morgia and S Serni Prostate Cancer Prostatic Dis 2017 20: 146-155; advance online publication, February 21, 2017; 10.1038/pcan.2017.1 Abstract | Full Text | | Original Articles | Top | | Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasisK Kuchta, Y Xiang, S Huang, Y Tang, X Peng, X Wang, Y Zhu, J Li, J Xu, Z Lin and T Pan Prostate Cancer Prostatic Dis 2017 20: 156-164; advance online publication, February 14, 2017; 10.1038/pcan.2016.61 Abstract | Full Text | | | | Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse modelE H Allott, E Macias, S Sanders, B S Knudsen, G V Thomas, S D Hursting and S J Freedland Prostate Cancer Prostatic Dis 2017 20: 165-171; advance online publication, February 28, 2017; 10.1038/pcan.2016.73 Abstract | Full Text | | | | TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancerM K Siu, W-Y Chen, H-Y Tsai, H-Y Chen, J J Yin, C-L Chen, Y-C Tsai and Y-N Liu Prostate Cancer Prostatic Dis 2017 20: 172-178; advance online publication, February 21, 2017; 10.1038/pcan.2017.2 Abstract | Full Text | | | | The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsyM Maruf, M Fascelli, A K George, M M Siddiqui, M Kongnyuy, J M DiBianco, A Muthigi, S Valayil, A Sidana, T P Frye, A Kilchevsky, P L Choyke, B Turkbey, B J Wood and P A Pinto Prostate Cancer Prostatic Dis 2017 20: 179-185; advance online publication, February 21, 2017; 10.1038/pcan.2016.46 Abstract | Full Text | | | | Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer OPENP L Nguyen, N E Martin, V Choeurng, B Palmer-Aronsten, T Kolisnik, C J Beard, P F Orio, M D Nezolosky, Y-W Chen, H Shin, E Davicioni and F Y Feng Prostate Cancer Prostatic Dis 2017 20: 186-192; advance online publication, January 24, 2017; 10.1038/pcan.2016.58 Abstract | Full Text | | | | Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, A Narang, N Radwan, S Robertson, T McNutt, A E Ross, D Y Song, T L DeWeese, P T Tran and P C Walsh Prostate Cancer Prostatic Dis 2017 20: 193-196; advance online publication, January 3, 2017; 10.1038/pcan.2016.64 Abstract | Full Text | | | | Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation studyR Mathieu, M Moschini, B Beyer, K M Gust, T Seisen, A Briganti, P Karakiewicz, C Seitz, L Salomon, A de la Taille, M Rouprêt, M Graefen and S F Shariat Prostate Cancer Prostatic Dis 2017 20: 197-202; advance online publication, January 10, 2017; 10.1038/pcan.2016.66 Abstract | Full Text | | | | End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerA K Narang, J Trieu, N Radwan, A Ram, S P Robertson, P He, C Gergis, E Griffith, H Singh, T A DeWeese, S Honig, A Annadanam, S Greco, C DeVille, T McNutt, T L DeWeese, D Y Song and P T Tran Prostate Cancer Prostatic Dis 2017 20: 203-209; advance online publication, January 17, 2017; 10.1038/pcan.2016.67 Abstract | Full Text | | | | Is prostate cancer stage migration continuing for black men in the PSA era?R W Dobbs, D T Greenwald, H Wadhwa, V L Freeman and M R Abern Prostate Cancer Prostatic Dis 2017 20: 210-215; advance online publication, January 17, 2017; 10.1038/pcan.2016.68 Abstract | Full Text | | | | Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complicationsN Singla, J Walker, S L Woldu, N M Passoni, K de la Fuente and C G Roehrborn Prostate Cancer Prostatic Dis 2017 20: 216-220; advance online publication, January 24, 2017; 10.1038/pcan.2016.70 Abstract | Full Text | | | | Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL OPENA H Bryce, J J Alumkal, A Armstrong, C S Higano, P Iversen, C N Sternberg, D Rathkopf, Y Loriot, J de Bono, B Tombal, S Abhyankar, P Lin, A Krivoshik, D Phung and T M Beer Prostate Cancer Prostatic Dis 2017 20: 221-227; advance online publication, January 24, 2017; 10.1038/pcan.2016.71 Abstract | Full Text | | | | Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, P Mullane, M Chappidi, S Joo, K Ghabili, J Agostino, K J Macura, H B Carter, E M Schaeffer, A W Partin, L J Sokoll and A E Ross Prostate Cancer Prostatic Dis 2017 20: 228-233; advance online publication, January 24, 2017; 10.1038/pcan.2016.72 Abstract | Full Text | | | | The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancerS A Patel, M-H Chen, M Loffredo, A Renshaw, P W Kantoff and A V D'Amico Prostate Cancer Prostatic Dis 2017 20: 234-240; advance online publication, January 24, 2017; 10.1038/pcan.2016.74 Abstract | Full Text | | | | Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapyJ V Hegde, D J Margolis, P-C Wang, R E Reiter, J Huang, M L Steinberg and M Kamrava Prostate Cancer Prostatic Dis 2017 20: 241-248; advance online publication, January 31, 2017; 10.1038/pcan.2016.75 Abstract | Full Text | | Letters to the Editor | Top | | Reply to 'Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy'M G Culha and O O Cakir Prostate Cancer Prostatic Dis 2017 20: 249; advance online publication, April 11, 2017; 10.1038/pcan.2017.17 Full Text | | Errata | Top | | Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasisK Kuchta, Y Xiang, S Huang, Y Tang, X Peng, X Wang, Y Zhu, J Li, J Xu, Z Lin and T Pan Prostate Cancer Prostatic Dis 2017 20: 250; advance online publication, March 28, 2017; 10.1038/pcan.2017.11 Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment